Ascend Wellness Holdings AAWH
OTC AAWH
$0.48 +0.02 (+5.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Depreciation & Amortization (CF) of $18.3 million for Q1 2026, down 0.65% year-over-year from $18.4 million in Q1 2025, and down 10.96% quarter-over-quarter from $20.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $18.3 million for Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 0.65% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $73.4 million (up 7.68% YoY), while the FY2025 annual figure was $73.5 million, up 11.14% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $18.3 million, down from $20.5 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $21.9 million in Q1 2023, with the low at $7.3 million in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $16.4 million (2024), against an average of $14.9 million.
  • The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) surged 121.22% in 2023, then declined 25.35% in 2024.
  • Ascend Wellness Holdings' Depreciation & Amortization (CF) stood at $11.3 million in 2022, then surged by 31.1% to $14.8 million in 2023, then increased by 18.1% to $17.5 million in 2024, then climbed by 17.52% to $20.5 million in 2025, then retreated by 10.96% to $18.3 million in 2026.
  • Business Quant data shows AAWH's Depreciation & Amortization (CF) at $18.3 million in Q1 2026, $20.5 million in Q4 2025, and $16.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 241.00 Mn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 Ascend Wellness Holdings 97.42 Mn 30.42 Mn 45.49 Mn 21.05 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.05 Mn
Jun 30, 2026 21.05 Mn
Mar 31, 2026 18.28 Mn
Mar 31, 2026 18.28 Mn
Dec 31, 2025 20.53 Mn
Dec 31, 2025 20.53 Mn
Sep 30, 2025 16.77 Mn
Sep 30, 2025 16.77 Mn
Jun 30, 2025 17.83 Mn
Jun 30, 2025 17.83 Mn
Mar 31, 2025 18.40 Mn
Mar 31, 2025 18.40 Mn
Dec 31, 2024 17.47 Mn
Dec 31, 2024 17.47 Mn
Sep 30, 2024 16.63 Mn
Sep 30, 2024 16.63 Mn
Jun 30, 2024 15.68 Mn
Jun 30, 2024 15.68 Mn
Mar 31, 2024 16.38 Mn
Mar 31, 2024 16.38 Mn